Viewing Study NCT05727059



Ignite Creation Date: 2024-05-06 @ 6:37 PM
Last Modification Date: 2024-10-26 @ 2:51 PM
Study NCT ID: NCT05727059
Status: COMPLETED
Last Update Posted: 2023-10-27
First Post: 2023-01-25

Brief Title: Magenta Elevate EFS in High-Risk PCI Patients
Sponsor: Magenta Medical Ltd
Organization: Magenta Medical Ltd

Study Overview

Official Title: Early Feasibility Study EFS of the Magenta Elevate Percutaneous Left Ventricular Assist Device pLVAD System in Patients Undergoing Non-emergent High-risk Percutaneous Coronary Interventions
Status: COMPLETED
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The Elevate EFS study is designed to evaluate the safety and feasibility of the Magenta Elevate percutaneous Left Ventricular Assist Device pLVAD System in patients undergoing non-emergent high-risk percutaneous coronary interventions
Detailed Description: The Elevate EFS is planned as a prospective single-arm interventional multi-center study enrolling up to 20 subjects

The Magenta Elevate Pump is a catheter-mounted self-expanding and retrievable pump designed to unload the left ventricle by actively transporting blood from the left ventricle into the ascending aorta

The Magenta Elevate is a temporary 6 hours ventricular support device indicated for use during high-risk percutaneous coronary interventions PCI performed electively or urgently in hemodynamically stable patients with severe coronary artery disease

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: True
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None